Paid Clinical Trials Columbus

Discover 1,324 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,324

Endovascular Therapy for Low NIHSS Ischemic Strokes

Recruiting

PHASE2

PHASE3

Sponsor:

Emory University

Location:

Columbus, Cincinnati, Cleveland, Lexingtonshow 32 more

Code:

NCT04167527

Conditions

Cerebral Ischemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device

Initial medical management (iMM)

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Recruiting

PHASE2

Sponsor:

New York Medical College

Location:

Columbus, Indianapolis, Milwaukee, Baltimoreshow 5 more

Code:

NCT03266627

Conditions

Adenovirus

Primary Immune Deficiency Disorder

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

cytotoxic t-lymphocytes

Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers

Recruiting

PHASE3

Sponsor:

Intercytex

Location:

Columbus, Ann Arbor, Kittanning, Erieshow 34 more

Code:

NCT00232973

Conditions

Leg Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ICXP007

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Columbus, Cincinnati, Mentor, Ann Arborshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Recruiting

PHASE2

Sponsor:

Mercator MedSystems, Inc.

Location:

Columbus, Chicago, Hyattsville, Raleighshow 9 more

Code:

NCT04858776

Conditions

Iliofemoral; Thrombosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Perivascular dexamethasone

Perivascular sham

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Columbus, West Chester, Cincinnati, Bethesdashow 6 more

Code:

NCT06311227

Conditions

Recurrent Hairy Cell Leukemia

Recurrent Hairy Cell Leukemia Variant

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Magnetic Resonance Imaging

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Columbus, Grove City, Gahanna, Dublinshow 395 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

Recruiting

PHASE2

Sponsor:

Alzheimer's Disease Cooperative Study (ADCS)

Location:

Columbus, Cleveland, Lexington, Ann Arborshow 17 more

Code:

NCT06223360

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Low Dose Benfotiamine

High Dose Benfotiamine

Placebo

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Recruiting

PHASE2

Sponsor:

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Location:

Columbus, Indianapolis, Grand Blanc, Memphisshow 4 more

Code:

NCT05540327

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

M5049 low dose

M5049 medium dose

M5049 high dose

Placebo

M5049 very high dose

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Recruiting

Sponsor:

Children's Oncology Group

Location:

Columbus, Cincinnati, Pittsburgh, Ann Arborshow 17 more

Code:

NCT05705531

Conditions

Cardiovascular Disorder

Clonal Hematopoiesis

Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 7 - 40

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Electronic Health Record Review

Magnetic Resonance Imaging

Survey Administration